Melatonin and the immune system

International Archives of Allergy and Immunology

Volumn 112, Issue 3, 1997, Pages 203-211

  Liebmann, Peter M ^a   Wölfler, Albert ^a   Felsner, Peter ^a   Hofer, Dietmar ^a   Schauenstein, Konrad ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Extrapineal synthesis; Immune system; Lymphatic system; Mechanisms of action; Melatonin; Melatonin effects; Melatonin receptors; Physiological role; Pineal immune functions

Indexed keywords

MELATONIN;

IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOREGULATION; NEUROENDOCRINE SYSTEM; PINEAL BODY; PRIORITY JOURNAL; REVIEW;

EID: 0031048162     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237455     Document Type: Article

References (110)

1. Pierpaoli W, Regelson W, Colman C: The mela-lonin miracle: Nature’s age-reversing, disease-fighting, sex-enhancing hormone, New York, Simon & Schuster 1995. pp 1-247.
2. Reiter RJ, Robinson J: Melatonin: Your body’s natural wonder drug, New York, Bantam Books 1995. pp 1-291.
3. Reichlin S: Neuroendocrine-immune interactions, N Engl J Med 1993;329:1246-1253.
4. Homo-Delarche F, Dardcnne M: The neuroendocrine-immune axis, Springer Semin Immu-nopathol 1993:14:221-238.
5. Madden KS, Sanders VM, Felton DL: Catecholamine influences and sympathetic neural modulation of immune responsiveness, Annu Rev Pharmacol Toxicol 1995:35:417-448.
6. Wilder RL: Neuroendocrine-immune system interactions and autoimmunity, Annu Rev Immunol 1995;13:307-338.
7. Lener AB, Case JD, Takahashi Y, Lee TH, Mori W: Isolation of melatonin, the pineal factor that lightens melanocytes, J Am Chem Soc 1958:80:25-87.
8. Lerner AB, Case JD, Heinzelman RV: Structure of melatonin. J Am Chem Soe 1959:81:6084-6085.
9. Huether G, Poeggeler B, Reimer A, George A: Effect of tryptophan administration on circulating melatonin levels in chicks and rats: Evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract, Life Sci 1992:51:945-953.
10. Launay JM, Lamaitre BJ, Ilusson HP, Dreux C, Hartmann L, DaPrada M: Melatonin synthesis by rabbit platelets, Life Sci 1982:31:1487-1494.
11. Finocchiaro LM, Arzt ES, Fernandez-Castelo S, Criscuolo M, Finkielman S, Nahmod VE: Serotonin and melatonin synthesis in peripheral blood mononuclear cells, stimulation by inter-feron-gamma as part of an immunomodulatory pathway, J Interferon Res 1988:8:705-716.
12. Finocchiaro LM, Nahmod VE, LaunayJM: Melatonin biosynthesis and metabolism in peripheral blood mononuclear leucocytes, Biochcm J 1991:280:727-731.
13. Finocchiaro LM, Polack F, Nahmod VE, Glikin GC: Sensitivity of human peripheral blood mononuclear leukocytes to visible light, Life Sci 1995:57:1097-1110.
14. Waldhauser F, Weiszenbacher G, Tatzer E, Gisinger B, Waldhauser M, Schemper M, Frisch H: Alterations in nocturnal serum melatonin levels in humans with growth and aging, J Clin Endocrinol Metab 1988;66:648-652.
15. Hofstätter R: Versuche der postoperativen Krebsbehandlung mit Zirbelstoffen, Krebsarzt 1959:14:307-316.
16. Lapin V: Pineal gland and malignancy, Ösler Z Onkol 1976:3:5160.
17. Blask DE, Hill SM: Melatonin and cancer: Basic and clinical aspects; in Miles A, Philbrick DRS, Thompson C (eds): Melatonin - Clinical Perspectives, London Oxford University Press, 1988. pp 128-173.
18. Cohen M, Lippman M, Chabner B: Role of pineal gland in aetiology and treatment of breast cancer, Lancet 1978:2:814-816.
19. Bartsch C, Bartsch H, Lippert TH, Gupta D: Effect of the mammary carcinogen 7.12-dimethy I-benz[a]anthracene on pineal melatonin biosynthesis, secretion and peripheral metabolism, Ncuroendocrinologv 1990:52:538-544.
20. Wetterberg L, Haiberg F, Tarquini B, Cagnoni M, Haus E, Griffith K, Kawasaki T, Wallach L-A, Ueno M, Uezo K, Matsuoka M, Kuzel M, Haiberg E, Omae T: Circadian variation in urinary melatonin in clinically healthy women in Japan and the United States of America, Expcri-entia 1979:35:416-418.
21. Bartsch C, Bartsch H, Jain AK, Laumas KR, Wetterberg L: Urinary melatonin levels in human breast cancer patients, J Neural Transm 1981:52:281-294.
22. Tamarkin L, Danforth D, Lichter A, DeMoss E, Cohen M, Chabner B, Lippman M: Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer, Science 1982:216:1003-1005.
23. Bartsch C, Bartsch H, Fuchs U, Lipperi TH, Bellmann O, Gupta D: Stage-dependent depression of melatonin in patients with primary breast cancer, Correlation with prolactin, thyroid stimulating hormone, and steroid receptors, Cancer 1989:64:426-433.
24. Blask DE, Lemus-Wilson AM, Wilson ST: Breast cancer: A model system for studying the neuroendocrine role of pineal melatonin in oncology, Biochem Soc Trans 1992;20:309-311.
25. Bariseli C, Bariseli H, Fluchter SH, Attanasio A, (iupta I): Evidence for modulation of melatonin secretion in men with benign and malignant tumors of the prostate: Relationship with the pituitary hormones, J Pineal Res 1985:2: 121-132.
26. Bartsch C, Bartsch H, Schmidt A, Ilg S, Bidder KH, Fluchter SH: Melatonin and 6-sulfatoxy-melatonin circadian rhythms in serum and urine of primary prostate cancer patients: Evidence for reduced pineal activity and relevance of urinary determinations, Clin Chini Acta 1992:209: 153-167.
27. Lissoni P, Barili S, Cattaneo G, Taneini G, Esposti G, Esposti D, Fraschini F: Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies, Oncology 1991:48:448-450.
28. Lissoni P, Band S, Ardizzoia A, Taneini G, Conti A, Maestroni G: A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastascs due to solid neoplasms, Cancer 1994:73:699-701.
29. Lissoni P, Barili S, Tancini G, Ardizzoia A, Ricci G, Aldcghi R, Brivio F, Tisi E, Rovelli F, Res-caldani R, et al: A randomised study with subcutaneous low dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neuplasms other than renal cancer and melanoma, Br J Cancer 1994:69:196-199.
30. Lissoni P, Barni S, Brivio F, Rossini F, Fumagalli L, Ardizzoia A, Tancini G: A biological study on the efficacy of low-dose subcutaneous interleukin-2 plus melatonin in the treatment of cancer-related thrombocytopenia, Oncology 1995: 52:360-362.
31. Webb SM, Puig-Domingo M: Role of melatonin in health and disease, Clin Endocrinol (Oxf) 1995:42:221-234.
32. Karasek M, Fraschini F: Is there a role for the pineal gland in neoplastic growth?; in Fraschini F, Reiter RJ (eds): Role of Melatonin and Pineal Peptides in Neuroimmunomodulation. New York. Plenum Press. 1993. pp 243-251.
33. Neri B, Brocchi A, Carossino AM, Cini-Neri G, Gemelli MT, Tommasi MS, Cagnoni M: Effects of melatonin administration on cytokine production in patients with advanced solid tumors. Oncol Rep 1995:2:45-47.
34. Blask DE: The Pineal: An Oncostatic Gland?, in Reiter RJ (ed): The Pineal Gland, New York, Raven Press, 1984. pp 253-284.
35. Pawlikowski M: The pineal gland and cell proliferation, in Reiter RJ, Karasek M (eds): Advances in Pineal Research, London, Libbey, 1986. pp 27-30.
36. Csaba G, Bodoky M, Toro I: Hormonal relationships of mastocytogencsis in lymphatic organs, II, Effect of epiphysectomy on the genesis of mast cells. Acta Anat (Basel) 1965:61:289-296.
37. Csaba G, Dunay C, Fischer J, Bodoky M: Hormonal relationships of mastocytogenesis in lymphatic organs, 3. Effect of the pineal body-thyroid-thymus system on mast cell production. Acta Anat (Basel) 1968:71:565-580.
38. Csaba G, Baratli P: Morphological changes of thymus and the thyroid gland after postnatal extirpation of pineal body. Endocrinol Exp 1975: 9:59-67.
39. Jankovic D, Isakovic K, Petrovic S: Effect of pincalectomy on immune reactions in the rat. Immunology 1970;18:1-6.
40. Maestroni GJ, Pierpaoli W: Pharmacologic control of the hormonally mediated immune response: in Ader R (ed): Psychoneuroimmunology, London. Academic Press, 1981. pp 405-413.
41. Maestroni GJ, Conti A, Pierpaoli W: Role of the pineal gland in immunity, Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J Neuro immunol 1986;13:19-30.
42. Maestroni GJ, Conti A, Pierpaoli W: Roleofthe pineal gland in immunity, II, Melatonin enhances the antibody response via an opiatergic mechanism. Clin Exp Immunol 1987:68:384-391.
43. Maestroni GJ, Conti A, Pierpaoli W: Role of the pineal gland in immunity, III. Melatonin antagonizes the immunsuppressivc effect of acute stress via an opiatergic mechanism. Immunology 1988:63:465-469.
44. Maestroni GJ, Conti A: β-Endorphin and dynorphin mimic the circadian immunoenhancing and anti-stress effects of melatonin. Int J Immunopharmacol 1989:11:333-340.
45. Maestroni GJ, Conti A: The pineal neurohor-monc melatonin stimulates activated CD4+, Thy-1+ cells to release opioid agonist(s) with immunoenhancing and anti-stress properties. J Neuroimmunol 1990:28:167-176.
46. Maestroni GJ, Conti A: Anti-stress role of the melatonin-immuno-opioid network: Evidence for a physiological mechanism involving T cell-derived, inununoreactive β-endorphin and MET-cnkcphalin binding to thymic opioid receptors. Int J Neurosci 1991;61:289-298.
47. Ovadia H, Nitsan P, Abramsky O: Characterization of opiate binding sites on mebranes of rat lymphocytes. J Neuroimmunol 1989:21:93-102.
48. Wajs E, Kutoh E, Gupta D: Melatonin affects proopiomelanocortin gene expression in the immune organs of the rat. Eur J Endocrinol 1995:133:754-760.
49. Maestroni GJ, Conti A, Lissoni P: Colony-stimulating activity and hematopoietic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin 4. Cancer Res 1994:54:4740-4743.
50. Maestroni GJ, Covacci V, Conti A: Hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophagc colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice. Cancer Res 1994:54:2429-2432.
51. Caroleo MC, Frasca D, Nistico G, Doria G: Melatonin as immunomodulator in immunodefi-cient mice. Immunopharmacology 1992:23: 81-89.
52. Caroleo MC, Doria G, Nistico G: Melatonin restores immunodepression in aged and cyclophosphamide-treated mice. Ann NY Acad Sci 1994;719:343-352.
53. Sze SF, Liu WK, Ng TB: Stimulation of murine splenocytes by melatonin and mcthoxytrypt-amine. J Neural Transm Gen Sect 1993:94:115-126.
54. Pioli C, Caroleo MC, Nistico G, Doria G: Melatonin increases antigen presentation and amplifies specific and non-specific signals for T-cell proliferation. Int J Immunopharmacol 1993:15: 463-468.
55. Lissoni P, Barni S, Ardizzoia A, Brivio F, Tancini G, Conti A, Maestroni GJ: Immunological effects of a single evening subcutaneous injection of low-dose interlcukin-2 in association with the pineal hormone melatonin in advanced cancer patients. J Biol Regul Homeost Agents 1992;6:132-136.
56. Lissoni P, Tisi E, Barni S, Ardizzoia A, Rovelli F, Rescaldani R, Ballabio D, Bencnti C, Angeli M, Tancini G: Biological and clinical results of a neuroimmunothcrapy with intcrleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer. Br J Cancer 1992;66:155-158.
57. Lissoni P, Barni S, Tancini G, Rovelli F, Ardizzoia A, Conti A, Maestroni GJ: A study of the mechanisms involved in the immunostimulatory action of the pineal hormone in cancer patients. Oncology 1993:50:399-402.
58. Maestroni GJ: T-helper-2 lymphocytes as a peripheral target of melatonin. J Pineal Res 1995; 18:84-89.
59. Ben-Nathan D, Maestroni GJ, Lustig S, Conti A: Protective effects of melatonin in mice infected with encephalitis viruses. Arch Virol 1995:140:223-230.
60. Axelrod J: The pineal gland: A neurochemical transducer. Science 1974:184:1341-1348.
61. Giordano M, Palermo MS: Melatonin-induced enhancement of antibody-dependent cellular cytotoxicity. J Pineal Res 1991:10:117-121.
62. Giordano M, Vennculen M, Palermo MS: Seasonal variations in antibody-dependent cellular cytotoxicity regulation by melatonin. FASEB J 1993:7:1052-1054.
63. Vennculen M, Palenno M, Giordano M: Neonatal pincalectomy impairs murine antibody-dependent cellular cytotoxicity. J Neuroimmunol 1993:43:97-101.
64. Felsner P, Hofer D, Rinner I, Mangge H, Gruber M, Korsatko LL, Schaucnstein K: Continuous in vivo treatment with catecholamines suppresses in vitro reactivity of rat peripheral blood T-lym-phocytes via-mediated mechanisms. J Neuroimmunol 1992;37:47-57.
65. 2,-receptors. J Neuroimmunol 1995:57:27-34.
66. McLeod SD, Cairncross KD: Preliminary evidence of a synergistic α1 and β1 -adrenoceptor regulation of rat pineal hydroxyindole-O-methyltransferase. Gen Comp Endocrinol 1995:97: 283-288.
67. Liebmann PM, Hofor D, Felsner P, Wölfler A, Schaucnstein K: Beta-blockade enhances adrenergic immunosuppression in rats via inhibition of melatonin release. J Neuroimmunol 1996:67: 137-142.
68. Konakchieva R, Kyurkchiev S, Kehayov I, Taushanova P, Kanehev L: Selective effect of mcthoxyindoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells. J Neuroimmunol 1995:63:125-132.
69. Vijayalaxmi L, Reiter RJ, Leal BZ, Meltz ML: Effect of melatonin on mitotic and proliferation indices, and sister chromatid exchange in human blood lymphocytes. Mutat Res 1996:351: 187-192.
70. Arzt ES, Femandez-Castelo S, Finocchiaro LM, Criscuolo ME, Diaz A, Finkielman S, Nahmod VF: Immunomodulation by indoleamines: Serotonin and melatonin action on DNA and in-terfcron-gamma synthesis by human peripheral blood mononuclear cells. J Clin Immunol 1988; 8:513-520.
71. Di-Stefano A, Paulcsu L: Inhibitory' effect of melatonin on production of IFN gamma orTNF alpha in peripheral blood mononuclear cells of some blood donors. J Pineal Res 1994; 17:164-169.
72. C'alvo JR, Rafii-el-Idrissi M, Pozo D, Guerrero JM: Immunomodulatory role of melatonin: Specific binding sites in human and rodent lymphoid cells. J Pineal Res 1995:18:119-126.
73. Maestroni GJ, Conti A: Melatonin in relation to the immune system; in Yu H-S, Reiter RJ (eds): Melatonin Biosynthesis, Physiological Effects, and Clinical Applications, Boca Raton, CRC Press, 1993. pp 289-309.
74. Lopez-Gonzalez MA, Calvo JR, Osuna C, Guerrero JM: Interaction of melatonin with human lymphocytes: Evidence for binding sites coupled to potentiation of cyclic AMP stimulated by vasoactive intestinal peptide and activation of cyclic GMP. J Pineal Res 1992:12:97-104.
75. Lopez-Gonzalez MA, Calvo JR, Osuna C, Rubio A, Guerrero JM: Synergistic action of melatonin and vasoactive intestinal peptide in stimulating cyclic AMP production in human lymphocytes’. J Pineal Res 1992; 12:174-180.
76. Lopez-Gonzalez MA, Calvo JR, Osuna C, Rubio A, Guerrero JM: Melatonin potentiates cyclic AMP production stimulated by vasoactive intestinal peptide in human lymphocytes. Neuro sci Lett 1992:136:150-152.
77. Gonzalcz-Haba MG, Garcia-Maurino S, Calvo JR, Gobema R, Guerrero JM: High-affinity binding of melatonin by human circulating T lymphocytes (CD4+). FASEB J 1995:9:1331-1335.
78. Vanecek J: Melatonin binding sites. J Neurochem 1988;51:1436-1440.
79. Reppcrt SM, Weaver DR, Rivkees SAH, Stopa EG: Putative melatonin receptors in a human biological clock. Science 1989:242:78-81.
80. Laitinen JT, Fltigge G, Saavedra JM: Characterization of melatonin receptors in the rat area postrcma: Modulation of affinity with cations and guanine nucleotides. Neuroendocrinology 1990:51:619-624.
81. l25I]iodomelatonin binding sites in spleen of birds and mammals.Neurosci Lett 1991:125:175-178.
82. l25I]iodomelatonin by spleen membrane preparations of chicken. J Pineal Res 1992:12:167-173.
83. Guerrero JM, Lopez-Gonzalez MA, Osuna C, Calvo JR: Specific binding of melatonin by immunocompetent cells in humans and rodents. Ann NY Acad Sci 1994;719:369-377.
84. l25I]iodomelatonin by nit splenocytes: Characterization and its role on regulation of cyclic AMP production.J Neuroimmunol 1995:57: 171-178.
85. Reppcrt SM, Weaver DR, Ebisawa T: Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994:13:1177-1185.
86. Pozo D, Delgado M, Fernandez-Santos JM, Calvo JR, Gomariz RO, Guerrero JM: Searching melatonin receptors on immune system: Gene expression of melatonin receptor in B and T subsets of lymphocytes (abstract 38), 7th Colloquium of the EPS, Sitges, 1996.
87. Reppert SM, Weaver DR: Melatonin madness, Cell 1995:83:1059-1062.
88. Becker-Andre M, Wiesenberg I, Schaeren-Wiemers NM, Andre E, Missbach M, Saurat JH, Carlberg C: Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily, J Biol Chem 1994:269: 28531-28534.
89. Wiesenberg I, Missbach M, Kahlen JP, Schrader M, Carlberg C: Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res 1995:23:327-333.
90. Stcinhilbcr D, Brungs M, Werz O, Wiesenberg I, Danielsson C, Kahlen JP, Nayeri S, Schrader M, Carlberg C: The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J Biol Chem 1995: 270:7037-7040.
91. Benitez-King G, Huerto-Delgadillo I., Anton-Tay F: Binding of H-melatonin to calmodulin. Life Sci 1993:53:201-207.
92. Benitez-King G, Anton-Tay F: Calmodulin mediates melatonin cytoskeletal effects. Experientia 1993:49:635-641.
93. Benitez-King G, Huerto-Delgadillo L, Anton-Tay F: Melatonin modifies calmodulin cell levels in MDCK and N1E-115 cell lines and inhibits phosphodiesterase activity in vitro. Brain Res 1991;557:289-292.
94. Benitez-King G, Rios A, Martinez A, Anton-Tay F: In vitro inhibition of Ca2+/calmodulin-dcpendcnt kinase II activity by melatonin. Bio-ehim Biophys Acta 1996:1290:191-196.
95. Pozo D, Reiter RJ, Calvo JR, Guerrero JM: Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci 1994:55:pp 455-460.
96. Wölfler A, Licbmann PM, Schauenstein K: Lack of calmodulin antagonism of melatonin in a human lymphoblastoid cell line. 3rd International Congress of the International Society for Ncuroimmunomodulation. Bethesda, 1996.
97. Money KM, McLachlan JA, Serkin CD, Ba-kouche O: Activation of human monocytes by the pineal hormone melatonin. J Immunol 1994:153:2671-2680.
98. Benitez-King G, Anton-Tay F: Calmodulin and, proiein kinase Ca are two Ca++-binding proteins that mediate intracellular melatonin signaling (abstract 15). 7th Colloquium of the EPS, Sitges, 1996.
99. Fleschcr E, Ledbetter JA, Schieven GL, Vela-Roch N, Fossum D, Dang H, Ogawa N, Taial N: Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. J Immunol 1994:153:4880-4889.
100. El-Hag A, Lisky PE, Bennett M, Clark RA: Immunomodulation by neutrophil myeloperoxidase and hydrogen peroxide: Differential susceptibility of human lymphocyte functions. J Immunol 1986:136:3420-3426.
101. Melchiorri D, Reiter RJ, Scvcrynek E, Chen LD, Nistico G: Melatonin reduces kainatc-in-duced lipid peroxidation in homogenatcs of different brain regions. FASEB J 1995:9: 1205-1210.
102. Reiter RJ: Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 1995:9:526-533.
103. Vijayalaxmi V, Reiter RJ, Severynek E, Poeggeler B, Leal BZ, Meltz ML: Marked reduction of radiation-induced micronuclei in human blood lymphocytes pretreated with melatonin. Radial Res 1995:143.102-106.
104. Vijayalaxmi V, Reiter RJ, Meltz ML: Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutat Res 1995:346:23-31.
105. Kramer J, Ben-David M: Prolactin suppression by (-)-D-9-tetrahydrocannabinol (THC): Involvement of scrotoninergic and dopaminergic pathways. Endocrinology 1978:103:452-457.
106. Lu KH, Meites J: Effects of serotonin precursors and melatonin on scrum prolactin release in rats. Endocrinology 1973:93:152-156.
107. Vaughan MK, Little JC, Johnson LY, Blask DE, Vaughan GM, Reiter RJ: Effects of melatonin and natural and synthetic analogues of arginine vasotocin on plasma prolactin levels in adult male rats. Florin Res 1978;9:236-246.
108. Gagnerault MC, Touraine Savino W, Kelly PA, Dardennc M: Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol 1993:150: 5673-5681.
109. Goctzl EJ, Sreedharan SP: Mediators of communication and adaption in the neuroendocrine and immune system, FASEB J 1992:6: 2646-2652.
110. Perscngiev SP, Kanehev LN, Stankov BM: Effect of melatonin on steroid production by rat adrenals under in vitro superperfusion conditions, Life Sci 1989:44:1955-1962.